Nanjing Vishee Medical Technology Co., Ltd (688580.SS)
CNY 51.38
(16.38%)
CNY 51.38
(16.38%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 27.1 Million CNY | 0.0% |
| 2022 | - CNY | -100.0% |
| 2021 | 1.81 Million CNY | -40.4% |
| 2020 | 3.04 Million CNY | -23.89% |
| 2019 | 4 Million CNY | -71.43% |
| 2018 | 14 Million CNY | -28.21% |
| 2017 | 19.5 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 27.74 Million CNY | -100.0% |
| 2024 Q1 | 1.00 CNY | 0.0% |
| 2024 Q3 | 28.06 Million CNY | 0.0% |
| 2023 Q2 | 2.00 CNY | 0.0% |
| 2023 Q3 | 1.00 CNY | -50.0% |
| 2023 FY | 27.1 Million CNY | 0.0% |
| 2023 Q4 | 27.1 Million CNY | 2710384300.0% |
| 2023 Q1 | - CNY | 0.0% |
| 2022 Q2 | 1.21 Million CNY | 1.86% |
| 2022 Q1 | 1.19 Million CNY | -34.16% |
| 2022 FY | - CNY | -100.0% |
| 2022 Q4 | - CNY | 0.0% |
| 2022 Q3 | - CNY | -100.0% |
| 2021 Q2 | 2.26 Million CNY | -35.31% |
| 2021 Q4 | 1.81 Million CNY | -21.27% |
| 2021 FY | 1.81 Million CNY | -40.4% |
| 2021 Q1 | 3.49 Million CNY | 0.0% |
| 2021 Q3 | 2.3 Million CNY | 1.9% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 FY | 3.04 Million CNY | -23.89% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q2 | 9 Million CNY | 0.0% |
| 2019 Q4 | 4 Million CNY | 0.0% |
| 2019 FY | 4 Million CNY | -71.43% |
| 2018 FY | 14 Million CNY | -28.21% |
| 2017 FY | 19.5 Million CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |